Diagnosis of bladder carcinoma using protoporphyrin IX fluorescence induced by 5-aminolaevulinic acid

BJU International

Volumn 83, Issue 1, 1999, Pages 129-135

  Koenig, F ^a,d   McGovern, F J ^b   Larne, R ^c   Enquist, H ^a   Schomacker, K T ^c   Deutsch, T F ^c  

^a CHARITÉ UNIVERSITÄTSMEDIZIN BERLIN   (Germany)

^b MASSACHUSETTS GENERAL HOSPITAL   (United States)

^c HARVARD MEDICAL SCHOOL   (United States)

^d HUMBOLDT UNIVERSITY   (Germany)

Author keywords

5 Aminolaevulinic acid; Bladder neoplasm; Diagnosis; Fluorescence; Protoporphyrin IX

Indexed keywords

AMINOLEVULINIC ACID; PROTOPORPHYRIN;

ADULT; AGED; ARTICLE; BLADDER BIOPSY; BLADDER CARCINOMA; CANCER DIAGNOSIS; CARCINOMA IN SITU; CLINICAL TRIAL; CYSTOSCOPY; DIAGNOSTIC VALUE; DYSPLASIA; FEMALE; FLUORESCENCE; HUMAN; INTRAVESICAL DRUG ADMINISTRATION; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; TRANSITIONAL CELL CARCINOMA;

ADULT; AGED; AGED, 80 AND OVER; AMINOLEVULINIC ACID; CYSTOSCOPY; FEMALE; FLUORESCENCE; HUMANS; MALE; MIDDLE AGED; PROTOPORPHYRINS; SENSITIVITY AND SPECIFICITY; URINARY BLADDER NEOPLASMS;

EID: 0032992931     PISSN: 14644096     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1464-410X.1999.00917.x     Document Type: Article

References (24)

1. 1 Kriegmair M, Baumgartner R, Knüchel R, Stepp H, Hofstädter F, Hofstetter A. Detection of early bladder cancer by 5-aminolevulinic acid induced porphyrin fluorescence. J Urol 1996; 155: 105
2. 2 Jichlinski P, Forrer M, Mizeret J et al. Clinical evaluation of a method for detecting superficial transitional cell carcinoma of the bladder by light-induced fluorescence of protoporphyrin IX following topical application of 5-aminolevulinic acid: preliminary results. Laser Surg Med 1997; 20: 402
3. 3 Meyer-Betz F. Untersuchungen über die biologische (photodynamische) Wirkung des Hämatoporphyrins und anderer Derivate des Blut-und Gallenfarbstoffs. Dtsch Arch Klin Med 1913; 112: 476
4. 4 Baumgartner R, Kriegmair M, Stepp HG et al. Photodynamic diagnosis following intravesical instillation of aminolevulinic acid (ALA): first clinical experiences in urology. In Dougherty TJ ed., Optical Methods for Tumor Treatment and Detection, Mechanisms and Techniques in Photodynamic Therapy II. Vol. 1881. Proc SPIE 1993: 20-5
5. 5 Koenig F, McGovern FJ. Fluorescence detection of bladder carcinoma. Urology 1997; 50: 778
6. 6 Kiemeney LALM, Witjes JA, Verbeek ALM, Heijbroek RP, Debruyne FMJ and the members of the Dutch South-East Co-operative Urological Group. The clinical epidemiology of superficial bladder cancer. Br J Cancer 1993; 67: 806
7. 7 Heil P, Stocker S, Sroka R, Baumgartner R. In vivo fluorescence kinetics of porphyrins following intravesical instillation of 5-aminolevulinic acid in normal and tumour-bearing rat bladders. J Photochem Photobiol B 1997; 38: 158
8. 8 Steinbach P, Weingandt H, Baumgartner R, Kriegmair M, Hofstaedter F, Knuchel R. Cellular fluorescence of the endogenous photosensitizer protoporphyrin IX following exposure to 5-aminolevulinic acid. Photochem Photobiol 1995; 62: 887
9. 9 Fellows GJ. Marshall DH. The permeability of human bladder epithelium to water and sodium. Invest Urol 1972; 9: 339
10. 10 Iinuma S, Bachor R, Flotte T, Hasan T. Biodistribution and phototoxicity of 5-aminolevulinic acid-induced PPIX in an orthotopic rat bladder tumor model. J Urol 1995; 153: 802
11. 11 Merk FB, Bendicht UP, Jacobs JB, Alroy J. Friedell GH, Weinstein RS. Malignant transformation of urinary bladder in humans and in N-[4-(5-nitro-2-furyl) -2-thiazolyl]formamide-exposed Fischer rats: ultrastructure of the major components of the permeability barrier. Cancer Res 1977; 37: 2843
12. 12 Kriegmair M, Wagner S, Stepp H, Hofstetter A. Fluoreszenzquantifizierung bei der 5-Aminolävulinsäure induzierten Kluoreszenzendoskopic des Harnblasenkarzinoms. Urologe A 1997; 36: 50 (Suppl.)
13. 13 Bryan GT, Morris CR. Absorption by the mouse and rat urinary bladder of glycine, tryptophan and glucose. Nature 1966; 210: 857
14. 14-labeled tryptophan, its metabolites, glycine, and glucose by the urinary bladder of the mouse. Invest Urol 1966; 3: 577
15. 15 Bridges JW, Sargent NSE, Upshall DG. Rapid absorption from the urinary bladder of a series of n-alkyl carbamates: A route for the recirculation of drugs. Br J Pharm 1979; 66: 283
16. 16 Moan J. Streckyte G, Badnonas S, Bech K. Photobleaching of protoporphyrin IX in cells incubated with 5-aminoIevulinic acid. Int J Cancer 1997; 70; 90
17. 17 Van der Veen N, De Bruijn HS, Star WM. Photobleaching during and re-appearance after photodynamic therapy of topical ALA-induced fluorescence in UVB-treated mouse skin. Int J Cancer 1997; 72: 110
18. 18 Kriegmair M, Baumgartner R, Lumper W, Waidelich R, Hofstetter A. Early clinical experience with 5-aminolevulinic acid for the photodynamic therapy of superficial bladder cancer. Br J Urol 1996; 77: 667
19. 19 Stocker S, Knüchel R, Sroka R, Kriegmair M, Steinbach P, Baumgartner R. Wavelength dependent photodynamic effects on chemically induced rat bladder tumors following intravesical instillation of 5-aminolevulinic acid. J Urol 1997; 157: 337
20. 20 Getzenberg RH, Konety BR, Oder TA et al. Bladder cancer-associated nuclear matrix proteins. Cancer Res 1996; 56: 1690
21. 21 Mao L, Schoenberg MP, Scicchitano M et al. Molecular detection of primary bladder cancer by microsatellite analysis. Science 1996; 271: 659
22. 22 Mulder A, Van Hooteg J. Sylvest R. Prognostic factors in bladder carcinoma: histologic parameters and expression of a cell cycle-related nuclear antigen (Ki-67). J Pathol 1992; 166: 37
23. 23 Waldman FM, Carrol PR, Cohen MB. 5-Bromodeoxyuridine incorporation and PCNA expression as measures of cell proliferation in transitional cell carcinoma of the urinary bladder. Mod Pathol 1993; 6: 20
24. 24 Knüchel R, Hartmann A, Füchsl K, Hofstädter F, Hofstetter A, Kriegmair M. Längsschnittuntersuchungen von Patienten mit einfachen Hyperplasien und pTa-Tumoren des Urothels nach Detektion mit 5-ALA. Urologe A 1997; 36: 27 (Suppl.)